Focus and Scope

Overview & Objectives

Jurnal Farmasi Indonesia is a peer-reviewed, open-access national journal published by the Indonesian Pharmacists Association (Ikatan Apoteker Indonesia - IAI). The journal serves as a premier scholarly communication platform dedicated to disseminating high-quality, innovative, and impactful scientific knowledge.

The primary objective of Jurnal Farmasi Indonesia is to foster scientific dialogue, bridge basic pharmaceutical sciences with clinical practice, and support evidence-based healthcare. The journal publishes original research articles, comprehensive review articles, systematic reviews & meta-analyses, mini-reviews, short communications, case reports, and letters to the editor across a broad spectrum of pharmaceutical sciences and professional pharmacy practice.

Focus and Scope

Jurnal Farmasi Indonesia welcomes well-designed and methodologically rigorous submissions in the following areas:

1. Clinical Pharmacy

  • Randomized controlled trials, observational studies, and interventional studies on medication use in patient care.

  • Evaluation of therapeutic efficacy, comparative effectiveness, safety outcomes, and adverse drug reactions (pharmacovigilance).

  • Clinical pharmacokinetics, therapeutic drug monitoring (TDM), and pharmacodynamics.

  • Pharmaceutical care models, medication reconciliation, medication therapy management (MTM), and clinical decision support interventions.

2. Community & Social Administrative Pharmacy

  • Innovations, quality assessment, and delivery of pharmaceutical services in community and primary care settings.

  • Public health pharmacy, assessment of community medication needs, and management of drug-related problems (DRPs).

  • Patient counseling techniques, health literacy, and behavioral interventions to enhance medication adherence.

  • Pharmacy practice policies, implementation science, regulatory affairs, pharmacoeconomics, and health outcomes research.

3. Pharmaceutical Chemistry

  • Design, synthesis, chemical characterization, and purity analysis of active pharmaceutical ingredients (APIs) and impurities.

  • Structure-Activity Relationship (SAR) and Quantitative Structure-Activity Relationship (QSAR) studies.

  • Development, validation, and optimization of novel analytical methods (spectroscopic, chromatographic, and electrochemical techniques).

  • Chemical stability, degradation pathways, and quality control of pharmaceutical substances.

4. Pharmaceutical Biology & Pharmacognosy

  • Bioassay-guided isolation, structural elucidation, and characterization of bioactive constituents from natural products (terrestrial plants, marine resources, and microorganisms).

  • Standardization, quality assessment, and phytochemical profiling of herbal medicines and extracts.

  • Pharmacological screening and biological activity assays of natural compounds.

  • Ethnobotanical, ethnopharmacological, and biodiversity-related natural product investigations.

5. Pharmacology & Toxicology

  • Investigations into the cellular and molecular mechanisms of drug action.

  • Preclinical in vitro and in vivo efficacy and safety screening of synthetic and natural drug candidates.

  • Pharmacokinetics (ADME: absorption, distribution, metabolism, and excretion) and pharmacodynamics.

  • Drug-drug, drug-herb, and drug-food interaction studies, as well as general and organ-specific toxicological assessments.

6. Drug Development & Medicinal Chemistry

  • In silico drug discovery, Computer-Aided Drug Design (CADD), molecular docking, and molecular dynamics simulations.

  • Target identification, validation, and molecular optimization of lead compounds.

  • Drug repurposing, prodrug design, and bioconjugate chemistry.

  • Pre-formulation chemistry supporting targeted and advanced therapeutics.

7. Pharmaceutics, Formulation, & Drug Delivery Systems

  • Pre-formulation studies, formulation design, and optimization of conventional dosage forms (tablets, capsules, semi-solids, liquids).

  • Development and characterization of novel drug delivery systems (NDDS) including nanoparticles, liposomes, nanoemulsions, polymeric micelles, and transdermal patches.

  • Modified release, targeted drug delivery, and stimulus-responsive systems.

  • Biopharmaceutics, dissolution profiling, drug stability testing, and bioavailability enhancement strategies.

Types of Articles Published

  • Original Research Articles: Full-length reports presenting novel, robust, and significant empirical findings that contribute fundamentally to the pharmaceutical sciences or practice.

  • Systematic Reviews & Meta-Analyses: Comprehensive, methodologically transparent syntheses that critically appraise and synthesize empirical evidence (preferably following reporting standards such as PRISMA).

  • Review Articles: Comprehensive critical overviews providing deep insights into recent trends, state-of-the-art developments, and future perspectives in specific pharmacy fields.

  • Mini-Reviews: Concise, focused reviews discussing timely topics, current controversies, or emerging paradigms in a compact format.

  • Short Communications: Concise peer-reviewed articles presenting urgent, high-impact findings, significant preliminary data, or breakthrough methodological advancements.

  • Case Reports: Informative and well-documented reports of rare clinical cases, unusual adverse drug events, or novel practical interventions encountered in clinical or community pharmacy practice.

  • Letters to the Editor: Constructive scholarly discourse, comments on articles published in recent issues, or brief communications highlighting critical matters of pharmaceutical interest.